Hannele Yki-Järvinen
Epidemiology · 2000–2022
A researcher in the Science corpus: 11 papers; trusts 4 researchers and is trusted by 3 researchers here, as inferred from the citation graph.
Subfields
- Epidemiology — 186 citations into it; #1,172 of 2,148 by trust here, #461 by citations
- Endocrinology, Diabetes and Metabolism — 135 citations into it; #320 of 623 by trust here, #141 by citations
- Physiology — 58 citations into it
- Cardiology and Cardiovascular Medicine — 34 citations into it
Whom Hannele Yki-Järvinen trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Hannele Yki-Järvinen overall
Papers from Hannele Yki-Järvinen's perspective
Ordered by how strongly the researchers Hannele Yki-Järvinen trusts endorse each paper. Same corpus, a different order for every researcher.
- Molecular mediators of hepatic steatosis and liver injury. (Journal of Clinical Investigation)
- Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase (Nature Medicine)
- Cloning of adiponectin receptors that mediate antidiabetic metabolic effects (Nature)
- Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. (New England Journal of Medicine)
- EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease (Obesity Facts)
- 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The… (Journal of the American College of Cardiology)
- Diabetic dyslipidaemia: from basic research to clinical practice* (Diabetologia)
- Of markets and rights: Discourse in the 2008 and 2013 Global Action Plan for the Prevention and Control of Noncommunicable Diseases
- Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. (Diabetes)
- Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. (Endocrine reviews)
Their papers
- Why Does Obesity Cause Diabetes? (2022) — 750 citations
- Advancing the global public health agenda for NAFLD: a consensus statement (2021) — 631 citations
- A new definition for metabolic associated fatty liver disease: an international expert consensus statement. (2020) — 3,051 citations
- Quantitative PCR provides a simple and accessible method for quantitative microbiota profiling (2020) — 335 citations
- EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease (2016) — 3,531 citations
- Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. (2014) — 1,128 citations
- Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. (2009) — 789 citations
- Fatty Liver: A Novel Component of the Metabolic Syndrome (2007) — 876 citations
- Overproduction of large VLDL particles is driven by increased liver fat content in man (2006) — 707 citations
- Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. (2000) — 1,071 citations
- Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group. (2000) — 600 citations